Zacks Research Has Negative Outlook of ResMed Q4 Earnings
ResMed Inc. (NYSE:RMD – Free Report) – Equities researchers at Zacks Research reduced their Q4 2025 earnings per share estimates for shares of ResMed in a note issued to investors on Wednesday, May 14th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings of $2.39 per share for the […]
ResMed Inc. (NYSE:RMD – Free Report) – Equities researchers at Zacks Research reduced their Q4 2025 earnings per share estimates for shares of ResMed in a note issued to investors on Wednesday, May 14th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings of $2.39 per share for the […]
